Annual event raises nearly $125,000 for research and outreach to eliminate hepatitis B that affects more than 12 million Americans and 2 billion people worldwide.
Conference Series LLC invites all the participants across the globe to attend Euro Vaccines 2016 conference going to be held during June 16-18, 2016 in Rome, Italy. The conference includes explicit keynote talks from distinguished scientists, plenary sessions, Poster competition, Young Researcher sessions, Symposiums, Workshop and Exhibitions.
Partnership with The Commonwealth Medical College establishes innovative way to deliver its Master of Biomedical Science degree at the Blumberg Institute.
SMi are delighted to have Professor Conrad Lichtenstein, Chief Scientific Officer from Nemesis Bioscience Ltd, deliver a keynote address at the 18th annual conference on Superbugs & Superdrugs taking place in London on the 16th-17th March.
The industry established event "Superbugs & Superdrugs" returns to London on 16th-17th March 2016 for its 18th annual show and is proud to have Dr. Prabhavathi Fernandes as one of the keynote speakers for 2016.
Dr. W. Thomas London helped discover the hepatitis B virus 50 years ago with Dr. Baruch S. Blumberg and is honored by the Hepatitis B Foundation's research institute for his transformational contributions.
The Baruch S. Blumberg Institute hosted the Shark Tank-style event at the Pennsylvania Biotech Center, and honored founders of Delaware Crossing Investor Group.
EYES IN™ Magazine Editor-in-Chief Vivian Van Dijk is pleased to share innovations from a variety of fields, including Technology, Health, Science and Photography. Interactive, ad-free EYES IN™ Magazine Digital Edition 44 shares insightful interviews, images and inspiration from the world's innovative creators.
The Hepatitis B Foundation (www.hepb.org) is pleased to announce that engineer and business owner Craig Esterly and pharmaceutical industry executive Wayne Yetter have joined its board of directors.
Satisfied Users & 
Approved Press Releases
